EUVIMEDOpdag EUVIMED
Crossref

Inhalation versus intraperitoneal oxytocin administration in Swiss-Albino Mice

Liana Kobylinska, Gabriel Geagulea, Vlad Berbecar, Mihai Stancu, Adriana Maria Stefan, Ana-Maria Zagrean, Leon Zagrean

Discoveries Reports · 2016

DOI: 10.15190/drep.2016.1 ↗

At a glance

Journal article in Discoveries Reports, 2016. Written by Liana Kobylinska and 6 co-authors.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: Oxytocin modulates several social behaviors, with research results focusing on its role as potential adjunctive dedication in psychiatric disorders. This raises the necessity for a less stressful, translational way of oxytocin delivery in animal models. The aim of this paper is to provide a comparison between mice’s open field test (OFT) behavior after a single inhalator (Inh), respectively intraperitoneal (IP) oxytocin administration. METHODS: Forty-four male Swiss-Albino mice were divided into three groups- oxytocin, no-procedure (control) and placebo, according to the administered substance. The substances were delivered either through IP injection, or through a 22 minutes nebulization. The mice in the oxytocin group received 1 UI of oxytocin, whereas those in the placebo group got the equivalent amount of saline. OFT was performed 30 to 90 minutes after the administration. RESULTS: The time spent in the center varied among the groups (F(4,44)=3.224, p=0.022), due to the fact that the mice that received inhalatory oxytocin spent more time in the center than those in the control group and than those that were administered the substances intraperitoneally. The mice that received IP oxytocin had fewer boli emissions than all the other mice, whereas the mice that received Inh oxytocin had more boli emissions that those that received placebo, either inhalatory or intraperitoneally. CONCLUSION: We may conclude that group inhalator delivery of oxytocin seems preferable to the intraperitoneal injection way, with higher anxiolytic effects at the same dose.

Cite

APA

Kobylinska, L., Geagulea, G., Berbecar, V., Stancu, M., Stefan, A. M., Zagrean, A., & Zagrean, L. (2016). Inhalation versus intraperitoneal oxytocin administration in Swiss-Albino Mice. Discoveries Reports. https://doi.org/10.15190/drep.2016.1

Vancouver

Kobylinska L, Geagulea G, Berbecar V, Stancu M, Stefan AM, Zagrean A, et al. Inhalation versus intraperitoneal oxytocin administration in Swiss-Albino Mice. Discoveries Reports. 2016. doi:10.15190/drep.2016.1

BibTeX
@article{Kobylinska2016,
  author = {Kobylinska, Liana and Geagulea, Gabriel and Berbecar, Vlad and Stancu, Mihai and Stefan, Adriana Maria and Zagrean, Ana-Maria and Zagrean, Leon},
  title = {Inhalation versus intraperitoneal oxytocin administration in Swiss-Albino Mice},
  journal = {Discoveries Reports},
  year = {2016},
  doi = {10.15190/drep.2016.1}
}
Start for free →